ArticleTransboundary and emerging diseases2025
Diversity of the H9N2 Avian Influenza Virus in Shandong Province, China.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- H9N2 avian influenza virus in Muscovy ducks: a nationwide epidemiological survey and vaccine efficacy assessment.Veterinary research · 2026Article
- Pathogen identification and analysis of broiler bronchial obstruction syndrome using high-throughput sequencing technology.Poultry science · 2026Article
- A cross-sectional study of avian influenza virus in poultry markets of Guangdong China, 2025.Frontiers in cellular and infection microbiology · 2026Article
- PB1 mutations as key drivers of influenza A virus evolution.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
H9N2 avian influenza virus (AIV) is one of the main pathogens causing respiratory disease in chicken; however, differentiating this virus from infectious bronchitis virus (IBV) and newcastle disease virus (NDV) only using clinical signs is difficult. In this study, 492 tracheal and lung tissue samples were collected from chicken farms in Shandong reporting respiratory symptoms and tested using Reverse Transcription-Polymerase Chain Reaction (RT-PCR) for the presence of H9N2 AIVs, IBVs, and NDVs. The H9N2 AIVs positive samples were inoculated with chicken embryos. Whole-genome sequences of the positive strains were obtained using Illumina MiSeq and analyzed for genetic evolution and key amino acid sites mutation. Seventy-two samples were positive for H9N2 subtype AIV, with a positive rate of 14.63%, while the positive rates of IBV and NDV were 6.10% and 0.41%, respectively. Thirty-four strains of H9N2 AIVs were obtained from positive samples. Phylogenetic tree analysis of HA and NA genes revealed that the 34 H9N2 AIV strains belonged to Y280-like and F/98-like branches, respectively. Clear temporalphylogenetic branching was observed, with some strains found in the "pre-2013 isolates" clade and others in the "post-2013 isolates" clade, which raised the possibility that strains in the former clade may have undergone recombination with viral strains from 10 years ago. Among the internal amino acid sites that are key to mammalian adaptation, all strains had an I368V mutation in the PB1 gene that enhanced viral transmissibility in mammals, and the PB2 genes of some strains were mutated to enhance the mammalian adaptation of I292V and A588V. Thus, the H9N2 AIV gene segments in Shandong have different degrees of recombination and gene variation, necessitating vigilant monitoring of virus variation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.